Efficacy of a diarylheptanoid derivative against Leishmania amazonensis

The activity of several diarylheptanoid derivatives (curcuminoids) was previously evaluated against Leishmania amazonensis promastigotes and among them the most active compound was the [1-(4-methoxy-phenyl)-7-(3,4-methoxy-4-hydroxy-phenyl)-1,6-heptadien-3, 5-dione]. This derivative was chosen to be...

Full description

Bibliographic Details
Main Authors: Alves Luciana Vignólio, Temporal Rosane Maria, Cysne-Finkelstein Léa, Leon Leonor Laura
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2003-01-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762003000400024
_version_ 1797756564905394176
author Alves Luciana Vignólio
Temporal Rosane Maria
Cysne-Finkelstein Léa
Leon Leonor Laura
author_facet Alves Luciana Vignólio
Temporal Rosane Maria
Cysne-Finkelstein Léa
Leon Leonor Laura
author_sort Alves Luciana Vignólio
collection DOAJ
description The activity of several diarylheptanoid derivatives (curcuminoids) was previously evaluated against Leishmania amazonensis promastigotes and among them the most active compound was the [1-(4-methoxy-phenyl)-7-(3,4-methoxy-4-hydroxy-phenyl)-1,6-heptadien-3, 5-dione]. This derivative was chosen to be assayed in vivo in a treatment trial. For these experiments, the curcuminoid compound was used in a concentration equivalent to the IC50/24 h, obtained from the previous study. Balb/c mice were inoculated subcutaneously in the footpad with L. amazonensis infective promastigotes and 4 weeks after the inoculation, the animals were treated with different schemes, varying from 1 to 3 doses. In all the experiments, Pentamidine Isethionate was used as reference drug under the same experimental conditions. The results showed that one dose was not enough to heal the lesion, however, with 2 and 3 doses the efficiency of the assayed compound was clear. On the other hand, treatment with Pentamidine Isethionate using the three different schemes was not satisfactory when compared to the curcuminoid derivative.
first_indexed 2024-03-12T18:03:20Z
format Article
id doaj.art-405a35ba12bc4868bbc6bc9c4a271b3b
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:03:20Z
publishDate 2003-01-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-405a35ba12bc4868bbc6bc9c4a271b3b2023-08-02T09:32:28ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602003-01-01984553555Efficacy of a diarylheptanoid derivative against Leishmania amazonensisAlves Luciana VignólioTemporal Rosane MariaCysne-Finkelstein LéaLeon Leonor LauraThe activity of several diarylheptanoid derivatives (curcuminoids) was previously evaluated against Leishmania amazonensis promastigotes and among them the most active compound was the [1-(4-methoxy-phenyl)-7-(3,4-methoxy-4-hydroxy-phenyl)-1,6-heptadien-3, 5-dione]. This derivative was chosen to be assayed in vivo in a treatment trial. For these experiments, the curcuminoid compound was used in a concentration equivalent to the IC50/24 h, obtained from the previous study. Balb/c mice were inoculated subcutaneously in the footpad with L. amazonensis infective promastigotes and 4 weeks after the inoculation, the animals were treated with different schemes, varying from 1 to 3 doses. In all the experiments, Pentamidine Isethionate was used as reference drug under the same experimental conditions. The results showed that one dose was not enough to heal the lesion, however, with 2 and 3 doses the efficiency of the assayed compound was clear. On the other hand, treatment with Pentamidine Isethionate using the three different schemes was not satisfactory when compared to the curcuminoid derivative.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762003000400024diarylheptanoidtreatment trialLeishmania amazonensisleishmaniasis
spellingShingle Alves Luciana Vignólio
Temporal Rosane Maria
Cysne-Finkelstein Léa
Leon Leonor Laura
Efficacy of a diarylheptanoid derivative against Leishmania amazonensis
Memorias do Instituto Oswaldo Cruz
diarylheptanoid
treatment trial
Leishmania amazonensis
leishmaniasis
title Efficacy of a diarylheptanoid derivative against Leishmania amazonensis
title_full Efficacy of a diarylheptanoid derivative against Leishmania amazonensis
title_fullStr Efficacy of a diarylheptanoid derivative against Leishmania amazonensis
title_full_unstemmed Efficacy of a diarylheptanoid derivative against Leishmania amazonensis
title_short Efficacy of a diarylheptanoid derivative against Leishmania amazonensis
title_sort efficacy of a diarylheptanoid derivative against leishmania amazonensis
topic diarylheptanoid
treatment trial
Leishmania amazonensis
leishmaniasis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762003000400024
work_keys_str_mv AT alveslucianavignolio efficacyofadiarylheptanoidderivativeagainstleishmaniaamazonensis
AT temporalrosanemaria efficacyofadiarylheptanoidderivativeagainstleishmaniaamazonensis
AT cysnefinkelsteinlea efficacyofadiarylheptanoidderivativeagainstleishmaniaamazonensis
AT leonleonorlaura efficacyofadiarylheptanoidderivativeagainstleishmaniaamazonensis